- Home
- ENPH vs INSP Comparison
ENPH vs INSP Comparison
Compare ENPH & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ENPH
- INSP
- Stock Information
- Founded
- ENPH 2006
- INSP 2007
- Country
- ENPH United States
- INSP United States
- Employees
- ENPH N/A
- INSP N/A
- Industry
- ENPH Semiconductors
- INSP Medical/Dental Instruments
- Sector
- ENPH Technology
- INSP Health Care
- Exchange
- ENPH Nasdaq
- INSP Nasdaq
- Market Cap
- ENPH 4.2B
- INSP 3.8B
- IPO Year
- ENPH 2012
- INSP 2018
- Fundamental
- Price
- ENPH $36.80
- INSP $76.64
- Analyst Decision
- ENPH Hold
- INSP Buy
- Analyst Count
- ENPH 30
- INSP 15
- Target Price
- ENPH $59.25
- INSP $155.79
- AVG Volume (30 Days)
- ENPH 8.7M
- INSP 1.1M
- Earning Date
- ENPH 10-21-2025
- INSP 11-03-2025
- Dividend Yield
- ENPH N/A
- INSP N/A
- EPS Growth
- ENPH 37.10
- INSP 756.73
- EPS
- ENPH 1.28
- INSP 1.74
- Revenue
- ENPH $1,482,823,000.00
- INSP $861,312,000.00
- Revenue This Year
- ENPH $12.97
- INSP $14.91
- Revenue Next Year
- ENPH N/A
- INSP $14.37
- P/E Ratio
- ENPH $28.84
- INSP $43.95
- Revenue Growth
- ENPH 4.39
- INSP 22.05
- 52 Week Low
- ENPH $29.89
- INSP $70.77
- 52 Week High
- ENPH $109.50
- INSP $216.01
- Technical
- Relative Strength Index (RSI)
- ENPH 48.08
- INSP 39.89
- Support Level
- ENPH $35.06
- INSP $70.77
- Resistance Level
- ENPH $41.28
- INSP $78.41
- Average True Range (ATR)
- ENPH 1.82
- INSP 3.05
- MACD
- ENPH -0.20
- INSP 0.41
- Stochastic Oscillator
- ENPH 27.97
- INSP 43.00
About ENPH Enphase Energy Inc.
Enphase Energy is a global energy technology company. It delivers smart, easy-to-use solutions that manage solar generation, storage, and communication on one platform. The company's microinverter technology primarily serves the rooftop solar market and produces a fully integrated solar-plus-storage solution. Enphase derives a majority of revenue from the United States.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.